Klexane

Enoxaparin sodium, the active ingredient in Klexane, is a low molecular weight heparin presented as a sterile solution for subcutaneous, intravenous and haemodialysis use. It is employed to prevent and treat venous thrombo‑embolism in a variety of clinical settings. GNH USA supplies Klexane as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Klexane, a low molecular weight heparin, is used in several thrombo‑embolic conditions: - Deep vein thrombosis (post‑surgical): prevents clot formation in patients undergoing orthopedic or abdominal surgery. - Acute deep vein thrombosis: treats existing clot by inhibiting further propagation. - Pulmonary embolism (prevention and treatment): reduces risk of embolic events in at‑risk patients. - Haemodialysis anticoagulation: maintains circuit patency during dialysis sessions. - Acute coronary syndrome (prevention of clot formation): limits thrombus growth after cardiac ischemic events.

Common Side Effects: - Injection site pain or bruising: mild discomfort at the administration site. - Minor bleeding: such as gum or nosebleeds. - Nausea or headache: transient and usually self‑limiting. - Dizziness: occasional light‑headed sensation. - Elevated liver enzymes: mild, reversible changes.

Serious or Rare Side Effects: - Severe bleeding: gastrointestinal, intracranial or surgical site hemorrhage. - Heparin‑induced thrombocytopenia (HIT): immune‑mediated platelet drop with paradoxical clotting. - Allergic reactions: rash, urticaria or anaphylaxis. - Spinal or epidural hematoma: risk after neuraxial procedures. - Liver dysfunction: significant elevation of transaminases.

Before using Klexane, consider the following precautions: - Renal impairment: adjust dose or monitor anti‑Xa activity. - Surgery or invasive procedures: discontinue appropriately to lower bleeding risk. - Concomitant antiplatelet therapy: increased potential for bleeding. - History of heparin‑induced thrombocytopenia: avoid use. - Pregnancy and breastfeeding: use only if clearly indicated. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Klexane may interact with several medicines. Monitor patients closely. Major Interactions (Avoid): - Concurrent therapeutic anticoagulants (e.g., warfarin, DOACs): risk of severe bleeding. - Spinal/epidural anesthesia or puncture: may cause hematoma. - High‑dose NSAIDs: amplify bleeding tendency.

Moderate Interactions (Monitor Closely): - Antiplatelet agents (aspirin, clopidogrel): increased bleeding risk. - SSRIs or SNRIs: potential for enhanced hemorrhage. - ACE inhibitors in renal impairment: monitor renal function and anti‑Xa levels.